Boston Megan 4
4 · Benitec Biopharma Inc. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2024-12-09+720,000→ 720,000 totalExercise: $12.18Exp: 2034-12-09→ Common Stock (720,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025.